Cita APA

Perez-Fidalgo, J. (. A., Iglesias, M. (., Bohn, U. (., Calvo, E. (., Garcia, Y. (., Guerra-Alia, E. (., . . . González-Martín, A. (. (2019). GEICO1601-ROLANDO: A multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer.

Citación estilo Chicago

Perez-Fidalgo, J.A. (José Alejandro)|||/items/a2048d89-9398-4346-b562-0d990edc5e82, M. (Maria)|||/items/4e6ff478-21d9-4276-8341-956f4a4b6c4e Iglesias, U. (Uriel)|||/items/a5cc88d0-8935-4bed-9c7f-6f3a819cfcaf Bohn, E. (E.)|||/items/e1429cfb-d4f2-4b94-a218-d38c1138fcce Calvo, Y. (Yolanda)|||/items/c32f86e1-9b28-467c-a054-12230b270a84 Garcia, E. (Eva)|||/items/cf3ee475-a372-496f-ba56-3a0252dd1e63 Guerra-Alia, L. (Luis)|||/items/0359bd9c-c77f-4fc5-99c5-1b77f0f9346e Manso, A. (Ana)|||/items/8ef9f524-e335-4f4c-bcac-42eb489645ab Santaballa, y A. (Antonio)|||/items/47e72e63-32d3-4a8a-91d5-2624d704fb4e González-Martín. GEICO1601-ROLANDO: A Multicentric Single Arm Phase II Clinical Trial to Evaluate the Combination of Olaparib and Pegylated Liposomal Doxorubicin for Platinum-resistant Ovarian Cancer. 2019.

Cita MLA

Perez-Fidalgo, J.A. (José Alejandro)|||/items/a2048d89-9398-4346-b562-0d990edc5e82, et al. GEICO1601-ROLANDO: A Multicentric Single Arm Phase II Clinical Trial to Evaluate the Combination of Olaparib and Pegylated Liposomal Doxorubicin for Platinum-resistant Ovarian Cancer. 2019.